3624 Axel Mark
- 172
- 00.00%
Axel Mark News
AXEL MARK: Notice of questions and answers regarding the financial results briefing for the 2nd quarter of the fiscal year ending September 2024
AXEL MARK: Ad distribution platforms “AXEL MARK DSP” and “AdRoute” in the post-cookie era strengthen distribution of retargeting advertisements
AXEL MARK: Summary of financial results for the 2nd quarter of the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
AXEL MARK: Notice regarding revisions to earnings forecasts
AXEL MARK: Financial results briefing materials for the 2nd quarter of the fiscal year ending September 2024
AXEL MARK: Notice Concerning the Recording of Non-Operating Profit
AXEL MARK: Quarterly Report - 32nd Quarter (2024/01/01 to 2024/03/31)
AXEL MARK: Confirmation letter
AXEL MARK: (Cancellation of disclosure matters) Notice of cancellation of basic agreements relating to stock transfer agreements involving changes in subsidiaries, etc.
Axel Mark: Notice Concerning Determination of the Details of Issuance of the 28th Stock Acquisition Rights (Paid Stock Options)
Accel Mark: Notice Concerning Issuance of the 28th Stock Acquisition Rights (Paid Stock Options)
Accel Mark: Quarterly Report - 32nd Quarter 1 (2023/10/01 - 2023/12/31)
Accel mark: confirmation
Accel Mark: Extraordinary Report
Axel Mark: Summary of financial results for the 1st quarter of the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
Axel Mark: Notice Concerning the Recording of Non-Operating Profit
Axel Mark: Financial results briefing materials for the 1st quarter of the fiscal year ending September 2024
Axel Mark: Obtaining a Class 2 medical device manufacturing and sales license to promote the healthcare business
Axel Mark: Launch of “AXEL MARK DSP,” an advertisement distribution platform for the post-cookie era
Axel Mark: Extraordinary Report
Analysis
Price Target
No Data
